Sysmex Poland

Early identification of haematologic malignancies using a complete blood count

Being diagnosed with haematologic malignancy actually happens either because the patient presents with certain symptoms or – as is becoming increasingly common – there are incidental findings during routine blood screening. This white paper describes how a complete blood count measured on Sysmex XN-Series analysers may reveal significant abnormalities and improve the incidental findings of haematologic malignancies or the relapse of cancer under treatment early on.
496 KB
Copyright © Sysmex Europe SE. All rights reserved.
Dear customer,

Thank you very much for your interest in our products. Due to legal restrictions, advertising for medical products that detect COVID-19 infections is not permitted outside of specialist fields. Therefore we ask you to confirm below that you belong to one of the following groups:

- health care professional
- a facility that serves human or animal health
- a person who lawfully works with medicine or medical devices, processes or treatments

This site is for 'Professionals' only. You are not authorised to view this page.